| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | -5.5% | Deutsche Bank | → $17 | Downgrades | Buy → Hold |
| 08/24/2023 | -5.5% | Jefferies | → $17 | Reiterates | Hold → Hold |
| 08/15/2023 | 11.17% | JP Morgan | → $20 | Initiates Coverage On | → Neutral |
| 06/30/2023 | -5.5% | Deutsche Bank | $19 → $17 | Upgrades | Hold → Buy |
| 05/31/2023 | -5.5% | Jefferies | → $17 | Reiterates | Hold → Hold |
| 05/08/2023 | -5.5% | Jefferies | $22 → $17 | Downgrades | Buy → Hold |
| 03/06/2023 | 5.61% | Deutsche Bank | $16.5 → $19 | Maintains | Hold |
| 02/28/2023 | 22.29% | Jefferies | → $22 | Reiterates | → Buy |
| 02/21/2023 | 22.29% | Jefferies | $17 → $22 | Maintains | Buy |
| 01/12/2023 | -8.28% | Deutsche Bank | $15 → $16.5 | Maintains | Hold |
| 11/29/2022 | -5.5% | Jefferies | $16 → $17 | Maintains | Buy |
| 09/06/2022 | -33.3% | Deutsche Bank | $7 → $12 | Maintains | Hold |
| 09/06/2022 | -11.06% | Jefferies | $11 → $16 | Upgrades | Hold → Buy |
| 08/25/2022 | -38.85% | Jefferies | $9 → $11 | Maintains | Hold |
| 05/25/2022 | -44.41% | HC Wainwright & Co. | $8 → $10 | Maintains | Neutral |
| 04/08/2022 | -49.97% | HC Wainwright & Co. | $8 → $9 | Maintains | Neutral |
| 02/18/2022 | -49.97% | Jefferies | $8 → $9 | Maintains | Hold |
| 11/29/2021 | -55.53% | Jefferies | $9 → $8 | Maintains | Hold |
| 05/25/2021 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 03/29/2021 | -55.53% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Neutral |
| 02/22/2021 | -55.53% | Jefferies | → $8 | Downgrades | Buy → Hold |
| 01/29/2021 | -55.53% | Jefferies | $8.5 → $8 | Maintains | Buy |
| 11/25/2020 | -52.75% | Jefferies | $9 → $8.5 | Maintains | Buy |
| 11/24/2020 | -60.03% | Danske Bank | → $7.19 | Downgrades | Buy → Hold |
| 10/28/2020 | — | Evercore ISI Group | Downgrades | In-Line → Underperform | |
| 10/23/2020 | -49.97% | Jefferies | $10 → $9 | Maintains | Buy |
| 10/21/2020 | — | BTIG | Downgrades | Buy → Neutral | |
| 05/28/2020 | -44.8% | DNB Markets | → $9.93 | Upgrades | Hold → Buy |
| 03/24/2020 | -44.41% | Jefferies | → $10 | Upgrades | Hold → Buy |
| 03/09/2020 | — | DNB Markets | Downgrades | Buy → Hold | |
| 10/18/2019 | -22.18% | Evercore ISI Group | → $14 | Upgrades | In-Line → Outperform |
| 09/13/2019 | -33.3% | BTIG | → $12 | Upgrades | Neutral → Buy |
| 01/10/2019 | -69.43% | Wells Fargo | $7 → $5.5 | Downgrades | Outperform → Market Perform |
| 12/04/2018 | -61.09% | Deutsche Bank | $6 → $7 | Maintains | Hold |
| 11/30/2018 | — | DNB Markets | Downgrades | Buy → Hold | |
| 11/19/2018 | -66.65% | Morgan Stanley | $5 → $6 | Maintains | Equal-Weight |
| 10/01/2018 | -66.65% | Jefferies | → $6 | Initiates Coverage On | → Hold |
| 09/27/2018 | — | BTIG | Initiates Coverage On | → Neutral | |
| 08/28/2018 | -66.65% | Deutsche Bank | $5 → $6 | Maintains | Hold |
What is the target price for Frontline (FRO)?
The latest price target for Frontline (NYSE: FRO) was reported by Deutsche Bank on August 25, 2023. The analyst firm set a price target for $17.00 expecting FRO to fall to within 12 months (a possible -5.50% downside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Frontline (FRO)?
The latest analyst rating for Frontline (NYSE: FRO) was provided by Deutsche Bank, and Frontline downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Frontline (FRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Frontline, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Frontline was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
Is the Analyst Rating Frontline (FRO) correct?
While ratings are subjective and will change, the latest Frontline (FRO) rating was a downgraded with a price target of $0.00 to $17.00. The current price Frontline (FRO) is trading at is $17.99, which is out of the analyst's predicted range.